Logo for MBX Biosciences Inc

MBX Biosciences Investor Relations Material

Latest events

Logo for MBX Biosciences Inc

Study Result

MBX Biosciences
Logo for MBX Biosciences

Q4 2024

17 Mar, 2025
Logo for MBX Biosciences

Study Result

7 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from MBX Biosciences Inc

Access all reports
MBX Biosciences Inc. is a U.S.-based biotechnology company focused on developing precision medicines for endocrine disorders. The company’s research and development efforts target rare hormonal conditions, with a focus on creating peptide therapies that improve patient outcomes. Leveraging proprietary technology, MBX Biosciences aims to design therapies that address specific needs in endocrinology, including disorders related to hormone deficiencies or imbalances. The company advances its drug candidates through preclinical and clinical stages, seeking to bring effective treatments to patients with unmet medical needs. The company is headquartered in Carmel, Indiana, and its shares are listed on the NASDAQ.